Studies on Time to Normal Return of C.S.F. Findings in Childhood T.B. meningitis.
- Author:
Hyo Duck KIM
1
;
Jae Koo LEE
Author Information
1. Department of pediatrics, College of Medicine, Chonnam National University, Kwangju, Korea.
- Publication Type:Original Article
- MeSH:
Child, Preschool;
Cough;
Female;
Fever;
Headache;
Humans;
Incidence;
Jeollanam-do;
Leukocytes;
Male;
Meningitis*;
Seasons;
Seizures;
Thorax;
Tuberculin Test;
Tuberculosis;
Tuberculosis, Meningeal;
Tuberculosis, Miliary;
Vomiting
- From:Journal of the Korean Pediatric Society
1979;22(5):353-359
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The following results were obtained through the clinical review of 71 cases among 256 cases of tuberculous meningitis treated at the Mokpo children's T.B. hospital during the seven-year period, January 1970 through December 1976. 1. The distribution by age was 83.1% of the patients less than 6 years of age and 25.4% were between 1 and 2 year old. Male to female ratio was similar. 2. Seasonal incidence was in the order of summer, spring, winter and autumn. 3. Family history of tuberculosis was found in 29.5% of cases. 4. The most common symptoms on admission were in the order of vomiting, fever, generalized convulsion, cough and headache. 5. Tuberculin test revealed positive reaction in 65.1% of cases. 6. Chest x-ray revealed tuberculous lesions in 70.4% and miliary tuberculosis were found in 8.4% of all cases. 7. Leukocytes count in the C.S.F. on admission were between 200 and 500/mm3 in 43.7% of the patients and mean count was 330/mm3 Sugar in C.S.F. was definitely reduced less than 40mg% in 77.4% of the patients and mean level was 27mg%. Protein content was elevated between 40 and 300mg% in 78.9% of the patients. 8. Time to normal return of C.S.F. findings ; Sugar returned to normal in 80.4% of the patients less than 7 months and average was 5 months. Protein returned to normal in 81.8% of the patients less than 5 months after therapy was started and average was 3.2 months Leukocytes count returned to normal in 22.5% of the patients between 4 and 5 months after therapy was started and returned to normal in 80.4% of the patients less than 7 months and average was 5 months.
